
Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration
- Author
- Xander Bertels (UGent) , Ahmed Edris Mohamed, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, Claus Vogelmeier, Nuria Olvera, Nazanin Zounemat Kermani, Alvar Agusti, Gavin C Donaldson, Jadwiga A Wedzicha, Guy Brusselle (UGent) , Helena Backman, Eva Rönmark, Anne Lindberg, Judith M Vonk, Kian Fan Chung, Ian M Adcock, Maarten van den Berge and Lies Lahousse (UGent)
- Organization
- Abstract
- Background The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. Methods This cross-sectional multicohort study included adults = 50 years from nine CADSET cohorts with spirometry data (N=69 789). AO was defined as ever diagnosed asthma with pre-BD or post-BD FEV1/FVC <0.7 in population-based and clinic-based cohorts, respectively. Clinical characteristics and comorbidities of AO were compared with asthma without airflow obstruction (asthma-only) and chronic obstructive pulmonary disease (COPD) without asthma history (COPD-only). ORs for comorbidities adjusted for age, sex, smoking status and body mass index (BMI) were meta-analysed using a random effects model. Results The prevalence of AO was 2.1% (95% CI 2.0% to 2.2%) in population-based, 21.1% (95% CI 18.6% to 23.8%) in asthma-based and 16.9% (95% CI 15.8% to 17.9%) in COPD-based cohorts. AO patients had more often clinically relevant dyspnoea (modified Medical Research Council score >= 2) than asthma-only (+14.4 and +14.7 percentage points) and COPD-only (+24.0 and +5.0 percentage points) in population-based and clinic-based cohorts, respectively. AO patients had more often elevated blood eosinophil counts (>300 cells/mu L), although only significant in population-based cohorts. Compared with asthma-only, AO patients were more often men, current smokers, with a lower BMI, had less often obesity and had more often chronic bronchitis. Compared with COPD-only, AO patients were younger, less often current smokers and had less pack-years. In the general population, AO patients had a higher risk of coronary artery disease than asthma-only and COPD-only (OR=2.09 (95% CI 1.26 to 3.47) and OR=1.89 (95% CI 1.10 to 3.24), respectively) and of depression (OR=1.41 (95% CI 1.19 to 1.67)), osteoporosis (OR=2.30 (95% CI 1.43 to 3.72)) and gastro-oesophageal reflux disease (OR=1.68 (95% CI 1.06 to 2.68)) than COPD-only, independent of age, sex, smoking status and BMI. Conclusions AO is a relatively prevalent respiratory phenotype associated with more dyspnoea and a higher risk of coronary artery disease and elevated blood eosinophil counts in the general population compared with both asthma-only and COPD-only.
- Keywords
- Pulmonary and Respiratory Medicine, Clinical Epidemiology, Asthma, Pulmonary Disease, Chronic Obstructive, COPD epidemiology, Asthma Epidemiology
Downloads
-
e001760.full.pdf
- full text (Published version)
- |
- open access
- |
- |
- 737.51 KB
-
Supplementary Material.pdf
- supplementary material
- |
- open access
- |
- |
- 633.94 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01H9J7PXXRK4T784F95QN0S5XJ
- MLA
- Bertels, Xander, et al. “Phenotyping Asthma with Airflow Obstruction in Middle-Aged and Older Adults : A CADSET Clinical Research Collaboration.” BMJ OPEN RESPIRATORY RESEARCH, vol. 10, no. 1, BMJ, 2023, doi:10.1136/bmjresp-2023-001760.
- APA
- Bertels, X., Edris Mohamed, A., Garcia-Aymerich, J., Faner, R., Meteran, H., Sigsgaard, T., … Lahousse, L. (2023). Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration. BMJ OPEN RESPIRATORY RESEARCH, 10(1). https://doi.org/10.1136/bmjresp-2023-001760
- Chicago author-date
- Bertels, Xander, Ahmed Edris Mohamed, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, et al. 2023. “Phenotyping Asthma with Airflow Obstruction in Middle-Aged and Older Adults : A CADSET Clinical Research Collaboration.” BMJ OPEN RESPIRATORY RESEARCH 10 (1). https://doi.org/10.1136/bmjresp-2023-001760.
- Chicago author-date (all authors)
- Bertels, Xander, Ahmed Edris Mohamed, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, Claus Vogelmeier, Nuria Olvera, Nazanin Zounemat Kermani, Alvar Agusti, Gavin C Donaldson, Jadwiga A Wedzicha, Guy Brusselle, Helena Backman, Eva Rönmark, Anne Lindberg, Judith M Vonk, Kian Fan Chung, Ian M Adcock, Maarten van den Berge, and Lies Lahousse. 2023. “Phenotyping Asthma with Airflow Obstruction in Middle-Aged and Older Adults : A CADSET Clinical Research Collaboration.” BMJ OPEN RESPIRATORY RESEARCH 10 (1). doi:10.1136/bmjresp-2023-001760.
- Vancouver
- 1.Bertels X, Edris Mohamed A, Garcia-Aymerich J, Faner R, Meteran H, Sigsgaard T, et al. Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration. BMJ OPEN RESPIRATORY RESEARCH. 2023;10(1).
- IEEE
- [1]X. Bertels et al., “Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration,” BMJ OPEN RESPIRATORY RESEARCH, vol. 10, no. 1, 2023.
@article{01H9J7PXXRK4T784F95QN0S5XJ, abstract = {{Background The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. Methods This cross-sectional multicohort study included adults = 50 years from nine CADSET cohorts with spirometry data (N=69 789). AO was defined as ever diagnosed asthma with pre-BD or post-BD FEV1/FVC <0.7 in population-based and clinic-based cohorts, respectively. Clinical characteristics and comorbidities of AO were compared with asthma without airflow obstruction (asthma-only) and chronic obstructive pulmonary disease (COPD) without asthma history (COPD-only). ORs for comorbidities adjusted for age, sex, smoking status and body mass index (BMI) were meta-analysed using a random effects model. Results The prevalence of AO was 2.1% (95% CI 2.0% to 2.2%) in population-based, 21.1% (95% CI 18.6% to 23.8%) in asthma-based and 16.9% (95% CI 15.8% to 17.9%) in COPD-based cohorts. AO patients had more often clinically relevant dyspnoea (modified Medical Research Council score >= 2) than asthma-only (+14.4 and +14.7 percentage points) and COPD-only (+24.0 and +5.0 percentage points) in population-based and clinic-based cohorts, respectively. AO patients had more often elevated blood eosinophil counts (>300 cells/mu L), although only significant in population-based cohorts. Compared with asthma-only, AO patients were more often men, current smokers, with a lower BMI, had less often obesity and had more often chronic bronchitis. Compared with COPD-only, AO patients were younger, less often current smokers and had less pack-years. In the general population, AO patients had a higher risk of coronary artery disease than asthma-only and COPD-only (OR=2.09 (95% CI 1.26 to 3.47) and OR=1.89 (95% CI 1.10 to 3.24), respectively) and of depression (OR=1.41 (95% CI 1.19 to 1.67)), osteoporosis (OR=2.30 (95% CI 1.43 to 3.72)) and gastro-oesophageal reflux disease (OR=1.68 (95% CI 1.06 to 2.68)) than COPD-only, independent of age, sex, smoking status and BMI. Conclusions AO is a relatively prevalent respiratory phenotype associated with more dyspnoea and a higher risk of coronary artery disease and elevated blood eosinophil counts in the general population compared with both asthma-only and COPD-only.}}, articleno = {{e001760}}, author = {{Bertels, Xander and Edris Mohamed, Ahmed and Garcia-Aymerich, Judith and Faner, Rosa and Meteran, Howraman and Sigsgaard, Torben and Alter, Peter and Vogelmeier, Claus and Olvera, Nuria and Kermani, Nazanin Zounemat and Agusti, Alvar and Donaldson, Gavin C and Wedzicha, Jadwiga A and Brusselle, Guy and Backman, Helena and Rönmark, Eva and Lindberg, Anne and Vonk, Judith M and Chung, Kian Fan and Adcock, Ian M and van den Berge, Maarten and Lahousse, Lies}}, issn = {{2052-4439}}, journal = {{BMJ OPEN RESPIRATORY RESEARCH}}, keywords = {{Pulmonary and Respiratory Medicine,Clinical Epidemiology,Asthma,Pulmonary Disease, Chronic Obstructive,COPD epidemiology,Asthma Epidemiology}}, language = {{eng}}, number = {{1}}, pages = {{9}}, publisher = {{BMJ}}, title = {{Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration}}, url = {{http://doi.org/10.1136/bmjresp-2023-001760}}, volume = {{10}}, year = {{2023}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: